Sacdalan, D. B., Lucero, J. A., & Sacdalan, D. (2018). Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: A review and meta-analysis. OncoTargets and therapy, 11, 955-965. https://doi.org/10.2147/OTT.S153290
Chicago Style (17th ed.) CitationSacdalan, Danielle Benedict, Josephine Anne Lucero, and Dennis Sacdalan. "Prognostic Utility of Baseline Neutrophil-to-lymphocyte Ratio in Patients Receiving Immune Checkpoint Inhibitors: A Review and Meta-analysis." OncoTargets and Therapy 11 (2018): 955-965. https://doi.org/10.2147/OTT.S153290.
MLA (9th ed.) CitationSacdalan, Danielle Benedict, et al. "Prognostic Utility of Baseline Neutrophil-to-lymphocyte Ratio in Patients Receiving Immune Checkpoint Inhibitors: A Review and Meta-analysis." OncoTargets and Therapy, vol. 11, 2018, pp. 955-965, https://doi.org/10.2147/OTT.S153290.